Rongxin Zhang

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Single-Cell RNA Editing Identifies T Cell ADAR1 as a Key Regulator of Immune Exhaustion and Anti-PD-1 Resistance in Colorectal Cancer.

|Nov 26, 2024
Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients.

Yu Feng, Wenjuan Ma, Yupeng Zang

|Nov 07, 2024
DDR1 is identified as an immunotherapy target for microsatellite stable colon cancer by CRISPR screening.

Miaoqing Wu, Wenjuan Ma, Guangzhao Lv

|Jul 08, 2022
PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma.

Jun-Cheng Wang, Dong-Ping Chen, Shi-Xun Lu

|May 06, 2022
Stage IV colon cancer patients without DENND2D expression benefit more from neoadjuvant chemotherapy.

Wen-Juan Ma, Yukun Chen, Jian-Hong Peng

Pageof 1

Frequent Collaborators

1 joint publications

Yukun Chen

1 joint publications

Xin-Pei Deng

1 joint publications

Jun-Cheng Wang

1 joint publications

Jin-Bin Chen